Sharechat Logo

BIF acquires shares in Calocurb

Wednesday 5th April 2023

Text too small?

Calocurb operates in the natural supplement part of the Life Sciences and Medical Technology sector. It specialises in appetite management, using a unique active ingredient sourced from New Zealand hops believed to be the only natural, non-prescriptive alternative to highly expensive prescription drugs to assist people with chronic and debilitating obesity. Calocurb was formed in 2017, and is classified as early stage, with its technology origins being from Plant and Food Research.

 

BIF will make a cash investment of $250,000. Following this transaction (and issue of additional units to fund the purchase), Calocurb will represent 1.7% of BIF’s investment portfolio of 32 companies, and with a net asset value of over $14.5 million.

 

Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of the process described in the fund’s Product Disclosure Statement (PDS) that is available at www.booster.co.nz

 

For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-innovation-fund.aspx

 

For more information, please contact:

Gary Scott

Company Secretary

Booster Investment Management Limited

04 8944300

 

About Booster

Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of the Booster Group which has been helping New Zealanders save since 1998. The group currently administers superannuation and investment funds of over $5 billion on behalf of more than 170,000 New Zealanders.

BIF is a managed investment fund that invests in early-stage companies founded on intellectual property originated or developed in New Zealand.

For more information, including a copy of the Product Disclosure Statement, please visit www.booster.co.nz

BIF acquires shares in Calocurb



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

WCO - James Redmayne to resign from executive role
Fletcher Building Market Update
Devon Funds Morning Note - 13 May 2024
GTK - Half-Year Results Investor Briefing Details
GNE - Huntly Firming Options
Chatham Closes Private Placement
May 13th Morning Report
Rakon FY2024 Results Announcement Date
WHS - The Warehouse Group FY24 Third Quarter Sales Update
May 10th Morning Report